On Cancer

Filter by Tag

Pictured: Robert Motzer & Suzanne Gornell

Video

Physicians and Scientists at Memorial Sloan-Kettering Pioneer the Development of Kidney Cancer Treatments

By Allyson Collins, MS, Science Writer/Editor | Wednesday, May 8, 2013

Our experts have participated in or led the development of five of the seven drugs approved by the US Food and Drug Administration for patients with advanced kidney cancer since 2005.

Tags: Cancer Care; Clinical Trials; Targeted Therapy; Treatment; Kidney Cancer; Research

Video

Memorial Sloan-Kettering Experts Discuss Awake Surgery for Brain Tumors

By Allyson Collins, MS, Science Writer/Editor | Monday, May 6, 2013

For some patients with brain tumors involving regions of the brain related to speech or movement, surgery is performed while the patient is awake, which can improve the procedure’s safety and effectiveness.

Tags: Cancer Care; Surgery; Brain Tumors; Treatment

Pictured: Health & Wellness Seminar Speakers

Event

Office of Diversity Programs Presents a Cancer Health and Wellness Seminar

By Celia Gittelson | Friday, May 3, 2013

More than 100 people participated in a community-based cancer health and wellness seminar sponsored by the Office of Diversity Programs as part of National Minority Cancer Awareness Month.

Tags: Cancer Care; Screening; Counseling & Support

In the Lab

Large Genetic Study Could Improve Endometrial Cancer Diagnosis and Treatment

By Jim Stallard, MA, Writer/Editor | Wednesday, May 1, 2013

An analysis of endometrial cancers reveals genetic information that should improve diagnosis and guide treatments for women with an aggressive form of the disease.

Tags: Cancer Care; Cancer Genetics; Endometrial Cancer; Research

In the Lab

Research Suggests a New Approach for Overcoming Resistance to a Targeted Therapy for Prostate Cancer

By Julie Grisham, MS, Science Writer/Editor | Tuesday, April 30, 2013

Research suggests that a new drug could be effective in patients with prostate cancer who develop resistance to the targeted therapy enzalutamide.

Tags: Cancer Biology; Cancer Care; Drug Discovery; Targeted Therapy; Prostate Cancer; Research

Profile

At Work: Physician-Scientist Liang Deng

By Jim Stallard, MA, Writer/Editor | Friday, April 26, 2013

Physician-scientist Liang Deng cares for patients with melanoma and other skin cancers, and also conducts innovative research on poxviruses.

Tags: Cancer Biology; Immunology; Treatment; Melanoma; Research

Video

Meet Urologic Cancer Surgeon Guido Dalbagni

By Memorial Sloan-Kettering | Tuesday, April 23, 2013

Dr. Dalbagni – who cares for patients with bladder cancer, kidney cancer, penile cancer, and sarcomas – explains treatments offered at Memorial Sloan-Kettering, which can help patients maintain their quality of life.

Tags: Bladder Cancer; Surgery; Treatment; Kidney Cancer; Soft Tissue Sarcoma

In the Clinic

Studies Show Promise for Treatment Advances in Several Types of Sarcoma

By Julie Grisham, MS, Science Writer/Editor | Monday, April 22, 2013

Two clinical trials of targeted therapies led by Memorial Sloan-Kettering investigators show promising results against different types of sarcoma.

Tags: Cancer Care; Clinical Trials; Bone Cancer; Targeted Therapy; Treatment; Soft Tissue Sarcoma; Research

Feature

Enhancing the Look and Feel of Memorial Sloan-Kettering for Patients and Staff

By Celia Gittelson | Friday, April 19, 2013

The Society of MSKCC’s Patient Environment Program funds projects aimed at enriching Memorial Hospital’s physical environment and the comfort of our patients.

Tags: Cancer Care; Pediatric Cancer Care; The Society of MSKCC; Giving

Finding

A Single Early PSA Test Found to Predict Long-Term Risk of Aggressive Prostate Cancer

By Allyson Collins, MS, Science Writer/Editor | Wednesday, April 17, 2013

A study led by Memorial Sloan-Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Tags: Cancer Care; PSA Testing; Diagnosis; Screening; Prostate Cancer; Research

Pictured: Megan Harlan Fleischut & Kenneth Offit

Q&A

Genetic Counseling and Genetic Screening for Cancer

By Julie Grisham, MS, Science Writer/Editor | Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan-Kettering’s clinical genetics experts.

Tags: Cancer Care; Genetic Testing; Screening

Event

Virtual Groups Provide Patients with Online Cancer Support and Education

By Julie Grisham, MS, Science Writer/Editor | Friday, April 12, 2013

Memorial Sloan-Kettering’s Virtual Groups program offers patients private, online support and education sessions to participate in from home or work.

Tags: Cancer Care; Virtual Groups; Counseling & Support

Video

Meet Leukemia Expert Dan Douer

By Memorial Sloan-Kettering | Wednesday, April 10, 2013

Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.

Tags: Cancer Care; Treatment; Leukemias; Research

Finding

Studies Report on Latest Advances in Targeted Therapy for Breast Cancer

By Julie Grisham, MS, Science Writer/Editor | Monday, April 8, 2013

Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.

Tags: Cancer Care; Clinical Trials; Targeted Therapy; Breast Cancer; Research

In the Clinic

Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma

By Media Staff | Thursday, April 4, 2013

Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

Tags: Cancer Care; Clinical Trials; Immunotherapy; Treatment; Melanoma; Research